JP2008506357A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008506357A5 JP2008506357A5 JP2007505491A JP2007505491A JP2008506357A5 JP 2008506357 A5 JP2008506357 A5 JP 2008506357A5 JP 2007505491 A JP2007505491 A JP 2007505491A JP 2007505491 A JP2007505491 A JP 2007505491A JP 2008506357 A5 JP2008506357 A5 JP 2008506357A5
- Authority
- JP
- Japan
- Prior art keywords
- env
- seq
- protein
- env protein
- fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04290838 | 2004-03-30 | ||
| EP04290838.4 | 2004-03-30 | ||
| PCT/EP2005/003339 WO2005095442A1 (en) | 2004-03-30 | 2005-03-30 | Polypeptide sequence involved in the modulation of the immunosuppresive effect of viral proteins |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008506357A JP2008506357A (ja) | 2008-03-06 |
| JP2008506357A5 true JP2008506357A5 (OSRAM) | 2011-02-03 |
| JP5060284B2 JP5060284B2 (ja) | 2012-10-31 |
Family
ID=34896141
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007505491A Expired - Fee Related JP5060284B2 (ja) | 2004-03-30 | 2005-03-30 | ウイルスタンパク質の免疫抑制作用のモデュレーションに関与するポリペプチド配列 |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US8178657B2 (OSRAM) |
| EP (1) | EP1732585B1 (OSRAM) |
| JP (1) | JP5060284B2 (OSRAM) |
| CN (1) | CN1961001B (OSRAM) |
| AT (1) | ATE472334T1 (OSRAM) |
| AU (1) | AU2005229411B2 (OSRAM) |
| BR (1) | BRPI0509497B1 (OSRAM) |
| CA (1) | CA2561376C (OSRAM) |
| DE (1) | DE602005022056D1 (OSRAM) |
| ES (1) | ES2347445T3 (OSRAM) |
| IL (1) | IL178205A (OSRAM) |
| MX (1) | MXPA06011272A (OSRAM) |
| WO (1) | WO2005095442A1 (OSRAM) |
| ZA (1) | ZA200608178B (OSRAM) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9777044B2 (en) | 2003-05-02 | 2017-10-03 | Centre National De La Recherche Scientifique (Cnrs) | GLUT-1 as a receptor for HTLV envelopes and its uses |
| WO2006103562A2 (en) | 2005-03-30 | 2006-10-05 | Centre National De La Recherche Scientifique (Cnrs) | Endogenous retrovirus and proteins encoded by env gene as a target for cancer treatment |
| US20070185025A1 (en) * | 2005-09-11 | 2007-08-09 | The Trustees Of Columbia University In The City Of New York | Filoviral immunosuppressive peptides and uses thereof |
| US20080299150A1 (en) * | 2007-05-08 | 2008-12-04 | Sankhia Corporation | Method and system for processing immuno-competent cells in view of an antiviral therapy, and related therapeutic process |
| US8323891B2 (en) * | 2008-08-01 | 2012-12-04 | Claflin University | miRNA triplex formations for the downregulation of viral replication |
| RU2008140688A (ru) * | 2008-10-15 | 2010-04-20 | Михаил Аркадьевич Шурдов (RU) | Иммуносупрессивный пептид |
| US9791435B2 (en) | 2009-01-09 | 2017-10-17 | Centre National De La Recherche Scientifique | Receptor binding ligands, their use in the detection of cells with biological interest |
| WO2011092199A1 (en) * | 2010-01-26 | 2011-08-04 | Institut Gustave Roussy | Mutated xmrv env proteins in the immunosuppressive domain |
| US20130197612A1 (en) | 2010-02-26 | 2013-08-01 | Jack W. Lasersohn | Electromagnetic Radiation Therapy |
| WO2012035369A1 (en) * | 2010-09-17 | 2012-03-22 | Centre National De La Recherche Scientifique | Method for the diagnosis and/or prognosis of inflammatory states |
| DK2734230T3 (en) * | 2011-07-20 | 2019-01-28 | Merial Ltd | RECOMBINANT FELINE LEUKEMIA VIRUS VACCINE CONTAINING OPTIMIZED FELINE LEUKEMIA VIRUS ENVELOPE GENE |
| IN2014CN04927A (OSRAM) * | 2011-12-07 | 2015-09-18 | Viroxis S A S | |
| US9636396B2 (en) | 2011-12-07 | 2017-05-02 | Centre National De La Recherche Scientifique | Mutant human and simian immunodeficiency virus ENV proteins with reduced immunosuppressive properties |
| EP3004143B1 (en) | 2013-06-07 | 2019-10-23 | Viroxis S.A.S. | Mutated non-primate lentiviral env proteins and their use as drugs |
| WO2016199674A1 (ja) * | 2015-06-11 | 2016-12-15 | 学校法人慶應義塾 | 融合タンパク質又は複合タンパク質、細胞内送達用担体、部分ペプチド、細胞膜透過促進剤、ｄｎａ、及びベクター |
| CN108368155A (zh) * | 2015-10-01 | 2018-08-03 | 爱姆维恩公司 | 人源性免疫抑制蛋白和肽作为药物的应用 |
| EP3676285B1 (en) * | 2017-09-01 | 2025-11-05 | InProTher ApS | A vaccine for use in the prophylaxis and/or treatment of a disease |
| JP7344300B2 (ja) | 2018-09-18 | 2023-09-13 | ブイエヌブイ ニューコ インク． | Ａｒｃベースのカプシドおよびその使用 |
| US11129892B1 (en) | 2020-05-18 | 2021-09-28 | Vnv Newco Inc. | Vaccine compositions comprising endogenous Gag polypeptides |
| AU2022208199A1 (en) | 2021-01-13 | 2023-07-13 | Centre National De La Recherche Scientifique | Measles-hiv or measles-htlv vaccine |
| AU2024256799A1 (en) | 2023-04-21 | 2025-11-06 | Inprother Aps | Improved expression of surface-displayed antigens |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4822606A (en) | 1986-04-07 | 1989-04-18 | Duke University | Immunosuppressive synthetic peptides and analogs thereof based on retroviral envelope sequences |
| AU4616289A (en) | 1988-12-13 | 1990-06-21 | Colorado State University Research Foundation | Prototype felv isolates for use in disease models and vaccines |
| FR2771011B1 (fr) * | 1997-11-17 | 2000-01-28 | Hippocampe | Obtention de vaccins destines a prevenir les effets pathogenes associes a une infection retrovirale |
| FR2780069B1 (fr) * | 1998-06-23 | 2002-06-28 | Inst Nat Sante Rech Med | Famille de sequences nucleiques et de sequences proteiques deduites presentant des motifs retroviraux endogenes humains et leurs applications |
| JP2003512844A (ja) * | 1999-10-28 | 2003-04-08 | ユニヴェルシテ・ドゥ・ジュネーブ | 多発性硬化症関連スーパー抗原 |
| JP2004517839A (ja) * | 2000-12-11 | 2004-06-17 | トゥフツ・ユニバーシティ | Ｅｂｖ感染およびｅｂｖ関連障害の処置および予防 |
| GB0112126D0 (en) | 2001-05-18 | 2001-07-11 | Allergene Inc | Composition |
-
2005
- 2005-03-30 WO PCT/EP2005/003339 patent/WO2005095442A1/en not_active Ceased
- 2005-03-30 MX MXPA06011272A patent/MXPA06011272A/es not_active Application Discontinuation
- 2005-03-30 ES ES05716455T patent/ES2347445T3/es not_active Expired - Lifetime
- 2005-03-30 JP JP2007505491A patent/JP5060284B2/ja not_active Expired - Fee Related
- 2005-03-30 BR BRPI0509497-6A patent/BRPI0509497B1/pt not_active IP Right Cessation
- 2005-03-30 DE DE602005022056T patent/DE602005022056D1/de not_active Expired - Lifetime
- 2005-03-30 US US11/547,399 patent/US8178657B2/en active Active
- 2005-03-30 CN CN2005800161375A patent/CN1961001B/zh not_active Expired - Fee Related
- 2005-03-30 CA CA2561376A patent/CA2561376C/en not_active Expired - Lifetime
- 2005-03-30 ZA ZA200608178A patent/ZA200608178B/xx unknown
- 2005-03-30 AU AU2005229411A patent/AU2005229411B2/en not_active Ceased
- 2005-03-30 AT AT05716455T patent/ATE472334T1/de not_active IP Right Cessation
- 2005-03-30 EP EP05716455A patent/EP1732585B1/en not_active Expired - Lifetime
-
2006
- 2006-09-20 IL IL178205A patent/IL178205A/en active IP Right Grant
-
2012
- 2012-02-17 US US13/399,208 patent/US8597657B2/en not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008506357A5 (OSRAM) | ||
| US20250327065A1 (en) | Disulfide-rich peptide libraries and methods of use thereof | |
| Henderson et al. | Primary structure of the low molecular weight nucleic acid-binding proteins of murine leukemia viruses. | |
| Dietrich et al. | Peptides as drugs: from screening to application | |
| JP7274228B2 (ja) | 病気の治療のためのポリペプチド | |
| JP2011523550A5 (OSRAM) | ||
| CN115246874B (zh) | 一种重组新型冠状病毒s-rbd三聚体蛋白、其制备方法和应用 | |
| JP2019506839A5 (OSRAM) | ||
| JP2014510519A5 (OSRAM) | ||
| JP7604368B2 (ja) | ストレス症候群、免疫反応症候群及び卒中症候群の処置のためのポリペプチド | |
| USRE44747E1 (en) | Mapping and reconstitution of a conformational discontinuous binding surface | |
| Hirsch et al. | Identification of a new subgroup of SIVagm in tantalus monkeys | |
| Darlak et al. | Facile preparation of disulfide‐bridged peptides using the polymer‐supported oxidant CLEAR‐OXTM | |
| Iglesias et al. | Structural information in therapeutic peptides: Emerging applications in biomedicine | |
| CN100577686C (zh) | 寡聚肽及其治疗hiv感染的用途 | |
| CN112543765A (zh) | 能够刺激细胞因子释放的新型肽及其衍生物 | |
| JP2009062372A (ja) | 高分子質量レクチンの生産 | |
| JP2019525764A5 (OSRAM) | ||
| JP2018533974A5 (OSRAM) | ||
| WO2021015237A1 (ja) | 抗体酵素の革新的製造技術 | |
| CN108546284B (zh) | Cd55特异性配体肽及其在用于制备抗肿瘤药物中的应用 | |
| US20060275309A1 (en) | Peptide oligomers for use as hiv vaccines | |
| CA2372456C (en) | Viral infection inhibitor targeting integrase n-terminal domain | |
| CN112300261B (zh) | 一种衍生自afp的肿瘤抗原短肽 | |
| JPWO2021262012A5 (OSRAM) |